Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Diagnostic Cytopathology|October 13, 2001
Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: an immunocytochemical studyA Simsir, P Fetsch, C W Bedrossian, et al.
Diagnostic Cytopathology|December 1, 1995
Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologic specimensA Abati, J S Sanford, P Fetsch, et al.
Cancer|December 19, 2001
Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary lookP A Fetsch, S M Steinberg, A I Riker, et al.
Diagnostic Cytopathology|June 1, 1996
Cytologic effects of photodynamic therapy in body fluidsO T Garza, A Abati, W F Sindelar, et al.
The American Journal of Surgical Pathology|June 1, 1993
Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosisD Zagzag, D C Miller, G M Kleinman, et al.
Cancer|August 24, 1999
Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytologyA Abati, X Sanjuan, A Wilder, et al.
Cancer|August 24, 1999
The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasmsA C Filie, A Chiesa, B R Bryant, et al.
Cancer|March 30, 1999
Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspirationP A Fetsch, F M Marincola, A Filie, et al.
Diagnostic Cytopathology|May 2, 2000
Detection of circulating tumor cells and micrometastases in stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistryP A Fetsch, K H Cowan, D E Weng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 28, 1998
Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumorP A Fetsch, J F Fetsch, F M Marincola, et al.
Pageof 5